Literature DB >> 21655831

A rapid detection of multidrug-resistant Mycobacterium tuberculosis by a nitrate reductase assay on blood agar.

Ahmet Yilmaz Coban1, Yeliz Tanriverdi Cayci, Aydin Deveci, Alper Akgunes, Meltem Uzun, Belma Durupinar.   

Abstract

The susceptibility of 49 Mycobacterium tuberculosis clinical isolates to isoniazid (INH) and rifampisin (RIF) (28 multi-drug resistant-tuberculosis samples) was determined by a nitrate reductase assay (NRA) on blood agar. Agreement between the NRA and other testing methods was found to be 93.8% for both INH and RIF. The sensitivity, specificity, positive predictive value and negative predictive value for INH were 92.8%, 94.2%, 86.6% and 97%, respectively. The sensitivity, specificity, positive predictive value and negative predictive value for RIF were 90.4%, 96.4%, 95% and 93.1%. In conclusion, we show here that blood agar can be used effectively for the NRA test.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21655831     DOI: 10.1590/s0074-02762011000300022

Source DB:  PubMed          Journal:  Mem Inst Oswaldo Cruz        ISSN: 0074-0276            Impact factor:   2.743


  3 in total

1.  Evaluation of agar-based medium with sheep sera for testing of drug susceptibility of Mycobacterium tuberculosis to Isoniazid, Rifampin, Ethambutol, and Streptomycin.

Authors:  Ahmet Yilmaz Coban; Meltem Uzun; Bulent Bozdogan
Journal:  J Clin Microbiol       Date:  2013-10-16       Impact factor: 5.948

Review 2.  Nitrate reductase assay for rapid detection of isoniazid, rifampin, ethambutol, and streptomycin resistance in Mycobacterium tuberculosis: a systematic review and meta-analysis.

Authors:  Ahmet Yilmaz Coban; Aydin Deveci; Ahmet Tevfik Sunter; Anandi Martin
Journal:  J Clin Microbiol       Date:  2013-10-16       Impact factor: 5.948

3.  Blood agar validation for susceptibility testing of isoniazid, rifampicin, ethambutol, and streptomycin to Mycobacterium tuberculosis isolates.

Authors:  Ahmet Yilmaz Coban
Journal:  PLoS One       Date:  2013-02-06       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.